Warberg Asset Management’s Clearmind Medicine CMND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18
Closed -$35.2K 241
2023
Q3
$35.2K Buy
+18
New +$82.4K 0.01% 139

Other funds holding CMND

Warberg Asset Management's CMND Position: Q4 2023 in Review

Warberg Asset Management sold out of Clearmind Medicine (CMND) in Q4 2023, closing a stake of 18 shares — an estimated $35.2K sold.

Warberg Asset Management first reported a position in CMND in Q3 2023 and held it in 1 quarter. The position peaked at $35.2K in Q3 2023. 1 fund tracked by Wall St. Rank holds CMND as of Q4 2023.

  • Warberg Asset Management reported no remaining Clearmind Medicine position as of Q4 2023 after selling out during the quarter.
  • Warberg Asset Management sold 18 Clearmind Medicine shares in Q4 2023, an estimated $35.2K.
  • Warberg Asset Management first reported a position in Clearmind Medicine in Q3 2023 and held it in 1 quarter.
  • Warberg Asset Management's Clearmind Medicine position peaked at $35.2K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Clearmind Medicine as of Q4 2023.

Based on Warberg Asset Management's 13F filing for Q4 2023, filed 7 Feb 2024.